The effects of CD26/DPP IV-targeted therapy on acute allograft rejection

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 1274-1275

  Korom, S ^a   De Meester, I ^b   Onodera, K ^a   Stadlbauer, T H W ^a   Borloo, M ^b   Lambeir, A M ^b   Kupiec Weglinski, J W ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ALLOGRAFT; ANIMAL TISSUE; CELL PROLIFERATION; CONFERENCE PAPER; DRUG EFFECT; ENZYME INHIBITION; GENE TARGETING; GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

EID: 0030985064     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00509-X     Document Type: Conference Paper

References (4)

1. Fox DA, Hussey RE, Fitzgerald KA, et al: J Immunol 133:1250, 1984
2. Tanaka T, Kameoka J, Yaron A, et al: Immunol 90:458, 1993
3. Hendriks D, De Meester I, Umiel T, et al: Clinica Chim Acta 196:87, 1991
4. Lambeir AM, Borloo M, De Meester I, et al: Biochimica Biophys Acta 1290:76, 1996